Literature DB >> 28658208

Recurrent and functional regulatory mutations in breast cancer.

Esther Rheinbay1,2, Prasanna Parasuraman2, Jonna Grimsby1, Grace Tiao1, Jesse M Engreitz1,3, Jaegil Kim1, Michael S Lawrence1,2, Amaro Taylor-Weiner1, Sergio Rodriguez-Cuevas4, Mara Rosenberg1, Julian Hess1, Chip Stewart1, Yosef E Maruvka1,2, Petar Stojanov1, Maria L Cortes1, Sara Seepo1, Carrie Cibulskis1, Adam Tracy1, Trevor J Pugh5, Jesse Lee2, Zongli Zheng2, Leif W Ellisen2,6, A John Iafrate2, Jesse S Boehm1, Stacey B Gabriel1, Matthew Meyerson1,6,7, Todd R Golub1,6,7, Jose Baselga8, Alfredo Hidalgo-Miranda9, Toshi Shioda2, Andre Bernards2, Eric S Lander1, Gad Getz1,2,6,10.   

Abstract

Genomic analysis of tumours has led to the identification of hundreds of cancer genes on the basis of the presence of mutations in protein-coding regions. By contrast, much less is known about cancer-causing mutations in non-coding regions. Here we perform deep sequencing in 360 primary breast cancers and develop computational methods to identify significantly mutated promoters. Clear signals are found in the promoters of three genes. FOXA1, a known driver of hormone-receptor positive breast cancer, harbours a mutational hotspot in its promoter leading to overexpression through increased E2F binding. RMRP and NEAT1, two non-coding RNA genes, carry mutations that affect protein binding to their promoters and alter expression levels. Our study shows that promoter regions harbour recurrent mutations in cancer with functional consequences and that the mutations occur at similar frequencies as in coding regions. Power analyses indicate that more such regions remain to be discovered through deep sequencing of adequately sized cohorts of patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28658208      PMCID: PMC5563978          DOI: 10.1038/nature22992

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  66 in total

1.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles.

Authors:  Albin Sandelin; Wynand Alkema; Pär Engström; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificities.

Authors:  Arttu Jolma; Teemu Kivioja; Jarkko Toivonen; Lu Cheng; Gonghong Wei; Martin Enge; Mikko Taipale; Juan M Vaquerizas; Jian Yan; Mikko J Sillanpää; Martin Bonke; Kimmo Palin; Shaheynoor Talukder; Timothy R Hughes; Nicholas M Luscombe; Esko Ukkonen; Jussi Taipale
Journal:  Genome Res       Date:  2010-04-08       Impact factor: 9.043

4.  E2F1 is crucial for E2F-dependent apoptosis.

Authors:  Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

5.  Lentiviral vectors to probe and manipulate the Wnt signaling pathway.

Authors:  Christophe Fuerer; Roel Nusse
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

6.  LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.

Authors:  Lucas Lochovsky; Jing Zhang; Yao Fu; Ekta Khurana; Mark Gerstein
Journal:  Nucleic Acids Res       Date:  2015-08-24       Impact factor: 16.971

7.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

8.  Recurrent somatic mutations in regulatory regions of human cancer genomes.

Authors:  Collin Melton; Jason A Reuter; Damek V Spacek; Michael Snyder
Journal:  Nat Genet       Date:  2015-06-08       Impact factor: 38.330

9.  Genome-wide analysis of noncoding regulatory mutations in cancer.

Authors:  Nils Weinhold; Anders Jacobsen; Nikolaus Schultz; Chris Sander; William Lee
Journal:  Nat Genet       Date:  2014-09-28       Impact factor: 38.330

10.  Functional impact bias reveals cancer drivers.

Authors:  Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nucleic Acids Res       Date:  2012-08-16       Impact factor: 16.971

View more
  108 in total

Review 1.  The Untranslated Regions of mRNAs in Cancer.

Authors:  Samantha L Schuster; Andrew C Hsieh
Journal:  Trends Cancer       Date:  2019-03-22

Review 2.  Holistic cancer genome profiling for every patient.

Authors:  Serena Nik-Zainal; Yasin Memari; Helen R Davies
Journal:  Swiss Med Wkly       Date:  2020-01-27       Impact factor: 2.193

3.  Differential Allele-Specific Expression Uncovers Breast Cancer Genes Dysregulated by Cis Noncoding Mutations.

Authors:  Pawel F Przytycki; Mona Singh
Journal:  Cell Syst       Date:  2020-02-19       Impact factor: 10.304

4.  Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.

Authors:  Rémi Buisson; Adam Langenbucher; Danae Bowen; Eugene E Kwan; Cyril H Benes; Lee Zou; Michael S Lawrence
Journal:  Science       Date:  2019-06-28       Impact factor: 47.728

5.  Cancer genomics: Less is more in the hunt for driver mutations.

Authors:  Sushant Kumar; Mark Gerstein
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

6.  Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms.

Authors:  Prashanth Krishna Shastrula; Peder J Lund; Benjamin A Garcia; Susan M Janicki
Journal:  J Biol Chem       Date:  2018-06-19       Impact factor: 5.157

7.  Promoter Mutation Analysis of ALDOA Gene in Solid Tumors and Acute Leukemias.

Authors:  Hyun Ji Son; Eun Ji Choi; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2018-11-14       Impact factor: 3.201

8.  Absence of Promoter Mutation in TBC1D12 Gene in Solid and Hematologic Neoplasia.

Authors:  Hyun Ji Son; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2018-09-10       Impact factor: 3.201

9.  Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.

Authors:  Alex J Cornish; Phuc H Hoang; Sara E Dobbins; Philip J Law; Daniel Chubb; Giulia Orlando; Richard S Houlston
Journal:  Blood Adv       Date:  2019-01-08

10.  IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.

Authors:  Jun Wang; Abu Z Dayem Ullah; Claude Chelala
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.